Emocha Mobile Health Inc Profile last edited on: 2/23/2018
CAGE: 73MG1
UEI: FHWGEP6NNLG1
Business Identifier: Improving medication adherence 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 02
County: Baltimore
Congr. District: 02
County: Baltimore
Public Profile
Emocha Mobile Health Inc is a healthcare IT company developing a mobile health platform,originally invented at Johns Hopkins University, that solves the issues of adherence, linkage to care, and data management for patients of diseases such as HIV, Hepatitis C, and others. The company's primary product is called miDot, a mobile phone application designed to enable Direct Observed Therapy without needing the care giver to be with the patient, improving medication adherence and efficiently linking patients to care. Redesigning the way patients take medication has the effect of improving medication adherence, strengthening patient-provider relationships, and reducing costs. Emocha works with payers and providers around the world iwith special focus inthe areas of tuberculosis, hepatitis C, HIV, and opioid addiction.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
15-19Revenue Range
1.5M-2MVC funded?
YesPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2024 | 2 | NIH | $1,676,047 | |
| Project Title: Evaluation of a mobile app-based video Directly Observed Therapy (video DOT) intervention for medication adherence in pediatric heart transplant patients | ||||
| 2024 | 2 | NIH | $1,254,751 | |
| Project Title: ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness) | ||||
| 2023 | 2 | NIH | $1,538,820 | |
| Project Title: Feasibility of Mhealth Technology-Enabled Service for Remote Observed Therapy of Methadone and Covid-19 Screening for Patients in an Opioid Treatment Program | ||||
| 2021 | 2 | NIH | $1,695,236 | |
| Project Title: Development and Evaluation of a Mobile Directly Observed Therapy Smartphone App for Immunosuppressive Adherence in Transplant Patients | ||||
| 2019 | 2 | NIH | $2,764,486 | |
| Project Title: Development and Evaluation of Video-Based Directly Observed Therapy for Office-Based Treatment of Opioid Use Disorders with Buprenorphine | ||||
Key People / Management
Jeffrey Daley -- Founder
Morad Elmi -- Co Founder
Sharon Kong -- Founder
Sebastian Seiguer -- Founder
Morad Elmi -- Co Founder
Sharon Kong -- Founder
Sebastian Seiguer -- Founder
